Safety Rates Drug Report: adverse events in 2016 Q3 - FDA prescription drugs adverse events in an open, searchable, online, public database

Drug Injury Quarter

Person who experienced the adverse event (patient)

Event ID	CASEID	CASEVERSION	I F COD	EVENT DT	MFR DT	INIT FDA DT	FDA DT	REPT COD	AUTH NUM	MFR NUM	MFR SNDR	LIT REF	AGE	AGE COD	AGE GRP	GNDR COD	E SUB	WT	WT COD	REPT DT	TO MFR	OCCP COD	REPORTER COUNTRY	OCCR COUNTRY
127588941	12758894	1	I	201604	20160912	20160919	20160919	EXP		US-ASTRAZENECA-2016SE97271	ASTRAZENECA		580.00	MON		F	Y	58.10000	KG	20160919		OT	US	US

Drug(s) used by person

Event ID	CASEID	DRUG SEQ	ROLE COD	DRUGNAME	PROD AI	VAL VBM	ROUTE	DOSE VBM	RECHAL	LOT NUM	NDA NUM	DOSE AMT	DOSE UNIT	DOSE FORM	DOSE FREQ
127588941	12758894	1	PS	FASLODEX	FULVESTRANT	1	Intramuscular	ONCE EVER MONTH	U		21344			INJECTION
127588941	12758894	2	SS	IBRANCE	PALBOCICLIB	1	Oral		U	N58282	0	100	MG	CAPSULE	QD
127588941	12758894	3	SS	IBRANCE	PALBOCICLIB	1	Oral		U	N58282	0	100	MG	CAPSULE	QD

Indications of drugs used

Event ID	CASEID	INDI DRUG SEQ	INDI PT
127588941	12758894	1	Neoplasm malignant
127588941	12758894	2	Breast cancer
127588941	12758894	3	Lung neoplasm malignant

Outcome of event

Event ID	CASEID	OUTC COD
127588941	12758894	OT

Reactions reported

Event ID	CASEID	DRUG REC ACT	PT
127588941	12758894		Hepatic lesion
127588941	12758894		Malignant neoplasm progression

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

no results found

Therapies reported

Event ID	CASEID	DSG DRUG SEQ	START DT	END DT
127588941	12758894	1	201604	20160829
127588941	12758894	2	201604	20160829
127588941	12758894	3	201604	20160829